The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock List

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Sat., Oct. 25, 3:45 AM

Slide #4. Nanosphere Secondary Offering

Company: Nanosphere (NASDAQ:NSPH)
Date announced: 10/21/2014
Shares Offered: 40,000,000
Date of Pricing: 10/22/2014
Price Per Share: $0.50
Secondary Offering Details: Nanosphere, Inc. (the "Company" or "Nanosphere") (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that it has commenced an underwritten public offering of its common stock. Chardan Capital Markets, LLC is acting as the sole book-running manager for the offering. Nanosphere plans to use the net proceeds from the offering for general corporate purposes and working capital. - updated 10/22 - Nanosphere, Inc. (the "Company") (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, today announced the pricing of its previously announced underwritten public offering of 40,000,000 shares of its common stock at a public offering price of $0.50 per share. In connection with the offering, the Company has also granted the underwriters a 30-day option to purchase up to an additional 6,000,000 shares of common stock to cover over-allotments, if any. As part of the fee payable to the underwriters in connection with the offering, the Company will issue 400,000 shares of common stock to the underwriters, plus up to an additional 60,000 shares of common stock in the event that the underwriters exercise their over-allotment option. Chardan Capital Markets, LLC is acting as the sole book-running manager for the offering.

Nanosphere is engaged in the development, manufacture and marketing of a molecular diagnostics platform, the Verigene® System, which enables clinicians to identify and treat the bacteria and viruses responsible for certain infectious diseases. The Verigene System includes a molecular diagnostics workstation that is a platform for genomic and protein testing. The Verigene System is comprised of a microfluidics processor, a touchscreen reader and disposable test cartridges. Co. is focused on the infectious disease diagnostics market.
Open the NSPH Page at The Online Investor »

Company Name:  Nanosphere Inc
Sector:  Biotechnology
Number of ETFs Holding NSPH:  1
Total Market Value Held by ETFs:  $77816
Total Market Capitalization:  $57.00M
% of Market Cap. Held by ETFs:  0.14%

Open the NSPH Page at The Online Investor (in a new window) »

October 25, 2014    3:45 AM Eastern
Quotes delayed 20 minutes

Buy (3.20 out of 4)
55th percentile
(ranked higher than approx. 55% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Secondary Stock Offerings | | Copyright © 1998 - 2014, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.